VRTXON

Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAFTA for the treatment of patients with CF 6 years of age or older who have at least one F508del mutation.

Kripto AdıVRTXON

SıralamaNo.3701

Piyasa Değeri$0.00

Tamamen Seyreltilmiş Değer$0.00

Pazar Payı%

İşlem Hacmi/Piyasa Değeri (24 Sa)56,014,783.30%

Dolaşımdaki Arz1.30452605

Maksimum Arz0

Toplam Arz1.30452605

Dolaşım Oranı%

Arz Tarihi--

Varlığın ilk arz edildiği fiyat--

Tüm Zamanların En Yükseği466.35223147502205,2026-03-26

En Düşük Fiyat414.92035330237934,2026-05-05

Herkese Açık Blok ZinciriETH

HakkındaVertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAFTA for the treatment of patients with CF 6 years of age or older who have at least one F508del mutation.

Sektör

Sosyal Medya

• Resmi Websitesi
• Blok Gezgini

etfindex:mc_etfindex_sourceYasal Uyarı: Veriler cmc tarafından sağlanmıştır ve yatırım tavsiyesi olarak değerlendirilmemelidir.